Moreover, given that KRAS and p16 are the two most commonly mutated genes in PDAC, and that RB dysfunction is also common in PDAC [32], KRC mice could be a useful GEMM for studying angiogenesis that reflects events in PDAC patients whose cancers exhibit a pro-angiogenic signature. Here, CDKN2A is linked to cancer.